JP2004524014A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004524014A5 JP2004524014A5 JP2002552000A JP2002552000A JP2004524014A5 JP 2004524014 A5 JP2004524014 A5 JP 2004524014A5 JP 2002552000 A JP2002552000 A JP 2002552000A JP 2002552000 A JP2002552000 A JP 2002552000A JP 2004524014 A5 JP2004524014 A5 JP 2004524014A5
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US25694000P | 2000-12-21 | 2000-12-21 | |
| PCT/CA2001/001853 WO2002050107A2 (en) | 2000-12-21 | 2001-12-21 | Streptococcus pyogenes antigens and corresponding dna fragments |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2004524014A JP2004524014A (ja) | 2004-08-12 |
| JP2004524014A5 true JP2004524014A5 (enExample) | 2005-12-22 |
| JP4080876B2 JP4080876B2 (ja) | 2008-04-23 |
Family
ID=22974225
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002552000A Expired - Fee Related JP4080876B2 (ja) | 2000-12-21 | 2001-12-21 | ストレプトコッカス・ピオゲネス抗原及び対応するｄｎａフラグメント |
Country Status (12)
| Country | Link |
|---|---|
| US (5) | US7595057B2 (enExample) |
| EP (1) | EP1343895B1 (enExample) |
| JP (1) | JP4080876B2 (enExample) |
| AT (1) | ATE398677T1 (enExample) |
| AU (2) | AU2002216863B8 (enExample) |
| BE (1) | BE2021C506I2 (enExample) |
| BR (1) | BR0116704A (enExample) |
| CA (2) | CA2789252C (enExample) |
| DE (1) | DE60134494D1 (enExample) |
| ES (1) | ES2307564T3 (enExample) |
| FR (1) | FR21C1005I2 (enExample) |
| WO (1) | WO2002050107A2 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7595057B2 (en) * | 2000-12-21 | 2009-09-29 | Id Biomedical Corporation | Streptococcus pyogenes antigens and corresponding DNA fragments |
| GB0130228D0 (en) * | 2001-12-18 | 2002-02-06 | Hansa Medica Ab | Protein |
| CA2535863A1 (en) * | 2003-08-15 | 2005-02-24 | Id Biomedical Corporation | Polypeptides of streptococcus pyogenes |
| GB201502305D0 (en) | 2015-02-12 | 2015-04-01 | Hansa Medical Ab | Protein |
| GB201502306D0 (en) | 2015-02-12 | 2015-04-01 | Hansa Medical Ab | Protein |
| AU2024241785A1 (en) * | 2023-03-29 | 2025-11-13 | Cyrus Biotechnology, Inc. | Ides variant proteins and methods of using the same |
Family Cites Families (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5854416A (en) * | 1991-11-14 | 1998-12-29 | The United States Of America As Represented By The Department Of Health And Human Services | Streptococcus pneumoniae 37-KDA surface adhesin a protein and nucleic acids coding therefor |
| US6287574B1 (en) | 1995-03-17 | 2001-09-11 | Biochem Pharma Inc. | Proteinase K resistant surface protein of neisseria meningitidis |
| TR200002437T2 (tr) * | 1998-02-20 | 2000-11-21 | Biochem Pharma Inc. | B grubu streptococcus antijenleri. |
| GB9807890D0 (en) * | 1998-04-09 | 1998-06-10 | Actinova Ltd | Peptides |
| EP1100921B1 (en) | 1998-07-27 | 2007-05-02 | Sanofi Pasteur Limited | Streptococcus pneumoniae proteins and nucleic acid molecules |
| EP1100920A2 (en) | 1998-07-27 | 2001-05-23 | Microbial Technics Limited | Nucleic acids and proteins from group b streptococcus |
| US7128918B1 (en) * | 1998-12-23 | 2006-10-31 | Id Biomedical Corporation | Streptococcus antigens |
| GB9828880D0 (en) * | 1998-12-31 | 1999-02-17 | Actinova Ltd | Protein |
| US7074415B2 (en) * | 2000-06-20 | 2006-07-11 | Id Biomedical Corporation | Streptococcus antigens |
| WO2002004495A2 (en) * | 2000-07-06 | 2002-01-17 | Shire Biochem Inc. | Streptococcus pyogenes antigen |
| WO2002031156A2 (en) * | 2000-10-13 | 2002-04-18 | Shire Biochem Inc. | Bvh-a2 and bvh-a3 antigens of group b streptococcus |
| ATE439372T1 (de) * | 2000-10-27 | 2009-08-15 | Novartis Vaccines & Diagnostic | Nukleinsäuren und proteine von gruppen a und b- streptokokken |
| US7595057B2 (en) * | 2000-12-21 | 2009-09-29 | Id Biomedical Corporation | Streptococcus pyogenes antigens and corresponding DNA fragments |
| BRPI0207447B1 (pt) * | 2001-02-21 | 2015-09-22 | Id Biomedical Corp | polipeptídeo recombinante isolado, seu uso e processo de produção, vetor de expressão, célula hospedeira microbiana transgênica, composição farmacêutica, uso da dita composição, métodos de detecção e kit |
| JP2004533236A (ja) * | 2001-04-13 | 2004-11-04 | ワイエス | 化膿性連鎖球菌（Ｓｔｒｅｐｔｏｃｏｃｃｕｓｐｙｏｇｅｎｅｓ）の表面タンパク質 |
| WO2003004650A2 (en) * | 2001-07-06 | 2003-01-16 | Shire Biochem Inc. | Group b streptococcus antigens and corresponding dna fragments |
| GB0130228D0 (en) * | 2001-12-18 | 2002-02-06 | Hansa Medica Ab | Protein |
| EP1456231A2 (en) * | 2001-12-20 | 2004-09-15 | Shire Biochem Inc. | Streptococcus antigens |
| WO2004007725A1 (en) * | 2002-07-15 | 2004-01-22 | Id Biomedical Corporation | Polypeptide of streptococcus pyogenes |
| CA2535863A1 (en) * | 2003-08-15 | 2005-02-24 | Id Biomedical Corporation | Polypeptides of streptococcus pyogenes |
| WO2006042027A2 (en) * | 2004-10-08 | 2006-04-20 | Novartis Vaccines And Diagnostics Inc. | Immunogenic and therapeutic compositions for streptococcus pyogenes |
| WO2006131347A2 (en) * | 2005-06-09 | 2006-12-14 | Hansa Medical Ab | Use of the ides proteinase (from s. pyogenes) for treating autoimmune diseases and graft rejection |
| US8309096B2 (en) * | 2007-01-15 | 2012-11-13 | Glaxosmithkline Biologicals S.A. | Fusion protein |
| JP5722627B2 (ja) * | 2007-09-14 | 2015-05-27 | ジェノビス エービー | ＦＣガンマ受容体−ＩｇＧ複合体の解離、ならびにＩｇＧの精製および検出のための方法およびキット |
| GB201003920D0 (en) * | 2010-03-09 | 2010-04-21 | Glaxosmithkline Biolog Sa | Method of treatment |
| GB201115841D0 (en) * | 2011-09-13 | 2011-10-26 | Genovis Ab | Protein and method |
| GB201316744D0 (en) * | 2013-09-20 | 2013-11-06 | Genovis Ab | Method |
| GB201416849D0 (en) * | 2014-09-24 | 2014-11-05 | Genovis Ab | Method |
-
2001
- 2001-12-21 US US10/451,337 patent/US7595057B2/en not_active Expired - Lifetime
- 2001-12-21 AT AT01271387T patent/ATE398677T1/de not_active IP Right Cessation
- 2001-12-21 AU AU2002216863A patent/AU2002216863B8/en not_active Ceased
- 2001-12-21 CA CA2789252A patent/CA2789252C/en not_active Expired - Fee Related
- 2001-12-21 BR BR0116704-9A patent/BR0116704A/pt not_active Application Discontinuation
- 2001-12-21 WO PCT/CA2001/001853 patent/WO2002050107A2/en not_active Ceased
- 2001-12-21 JP JP2002552000A patent/JP4080876B2/ja not_active Expired - Fee Related
- 2001-12-21 EP EP01271387A patent/EP1343895B1/en not_active Expired - Lifetime
- 2001-12-21 CA CA2432525A patent/CA2432525C/en not_active Expired - Fee Related
- 2001-12-21 ES ES01271387T patent/ES2307564T3/es not_active Expired - Lifetime
- 2001-12-21 DE DE60134494T patent/DE60134494D1/de not_active Expired - Lifetime
- 2001-12-21 AU AU1686302A patent/AU1686302A/xx active Pending
-
2009
- 2009-09-28 US US12/568,457 patent/US8298551B2/en not_active Expired - Fee Related
-
2012
- 2012-10-24 US US13/659,233 patent/US8821895B2/en not_active Expired - Lifetime
-
2014
- 2014-07-31 US US14/448,719 patent/US9340586B2/en not_active Expired - Fee Related
-
2016
- 2016-04-14 US US15/099,268 patent/US20160326221A1/en not_active Abandoned
-
2021
- 2021-02-04 FR FR21C1005C patent/FR21C1005I2/fr active Active
- 2021-02-09 BE BE2021C506C patent/BE2021C506I2/fr unknown